| pubmed-article:2401674 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2401674 | lifeskim:mentions | umls-concept:C1707496 | lld:lifeskim |
| pubmed-article:2401674 | lifeskim:mentions | umls-concept:C2364326 | lld:lifeskim |
| pubmed-article:2401674 | lifeskim:mentions | umls-concept:C0376554 | lld:lifeskim |
| pubmed-article:2401674 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:2401674 | lifeskim:mentions | umls-concept:C0037424 | lld:lifeskim |
| pubmed-article:2401674 | lifeskim:mentions | umls-concept:C0027689 | lld:lifeskim |
| pubmed-article:2401674 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2401674 | pubmed:dateCreated | 1990-10-23 | lld:pubmed |
| pubmed-article:2401674 | pubmed:abstractText | In 1986, a survey was conducted to assess knowledge, health concerns and experience with marketing (retailers) and use (consumers) of Gulaf and Nilocon pills and Kamal vaginal tablets distributed by the Nepal Contraceptive Retail Sales Company (CRS). A sample of 763 consumers of Gulaf, Nilocon and Indian pills and Kamal vaginal tablets, and 361 retailers from a stratified sample of urban medical shops were interviewed. The CRS marketing programme is reaching people who have previously never used family planning; most of the users were practising contraception to limit, not space, births; a high proportion of pill users over 35 smoked; only about a third of CRS pill users had prescriptions or consulted a physician prior to use; CRS training of retailers was found to have increased their knowledge. Recommendations are made for improving communication, education and marketing of CRS contraceptives to ensure their safe and effective use and increase the acceptability of this mode of service delivery. | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2401674 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2401674 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2401674 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2401674 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:2401674 | pubmed:issn | 0021-9320 | lld:pubmed |
| pubmed-article:2401674 | pubmed:author | pubmed-author:KaneT TTT | lld:pubmed |
| pubmed-article:2401674 | pubmed:author | pubmed-author:HamalHH | lld:pubmed |
| pubmed-article:2401674 | pubmed:author | pubmed-author:ShresthaAA | lld:pubmed |
| pubmed-article:2401674 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2401674 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:2401674 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2401674 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2401674 | pubmed:pagination | 305-22 | lld:pubmed |
| pubmed-article:2401674 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2401674 | pubmed:otherAbstract | PIP: A 1986 evaluation of the Nepal Contraceptive Retail Sales (CRS) program indicated that, while there is a need for improvements in IEC and marketing of subsidized contraceptives, the program is reaching unprecedented numbers of 1st-time family planning acceptors. The sample included 763 users of Gulaf, Nilocon, and Indian oral contraceptives (OCs) and Kamal vaginal tablets and 361 retailers from urban medical shops. 91% of the acceptors had learned of CRS products through radio advertisements. Only half made the contraceptive purchase themselves. Convenience--proximity to home or work and less waiting time--was the major reason given for buying contraceptives from private medical shops rather than government sources (where contraceptive supplies are free). 75% of Gulaf consumers and 50% of Nilocon and Kamal consumers were 1st-time contraceptives users, indicating that the CRS is reaching a new audience. Gulaf users were of lower socioeconomic status than acceptors of the other CRS products. Both consumers and retailers have a good basic understanding of the contraindications, method of use, and side effects of OCs and the vaginal foaming tablet. On the other hand, there were important gaps in knowledge. For example, retailers were not clear that Kamal can be used by lactating women and unsure of how to counsel consumers who had missed 3 consecutive pills. In addition, 6% of Gulaf and 8% of Nilocon consumers were smokers over 35 years of age--a category of women for whom OC use is contraindicated. Married, higher educated retailers had the highest levels of correct knowledge about CRS products. It appeared that husbands who purchased contraceptives for their wives either were not given adequate information about proper use or failed to transmit this information. Retailers expressed interest in expanding their stock to include Depo-Provera, pregnancy detection kits, and delivery kits. | lld:pubmed |
| pubmed-article:2401674 | pubmed:meshHeading | pubmed-meshheading:2401674-... | lld:pubmed |
| pubmed-article:2401674 | pubmed:meshHeading | pubmed-meshheading:2401674-... | lld:pubmed |
| pubmed-article:2401674 | pubmed:meshHeading | pubmed-meshheading:2401674-... | lld:pubmed |
| pubmed-article:2401674 | pubmed:meshHeading | pubmed-meshheading:2401674-... | lld:pubmed |
| pubmed-article:2401674 | pubmed:meshHeading | pubmed-meshheading:2401674-... | lld:pubmed |
| pubmed-article:2401674 | pubmed:meshHeading | pubmed-meshheading:2401674-... | lld:pubmed |
| pubmed-article:2401674 | pubmed:meshHeading | pubmed-meshheading:2401674-... | lld:pubmed |
| pubmed-article:2401674 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2401674 | pubmed:articleTitle | Contraceptive social marketing in Nepal: consumer and retailer knowledge, needs and experience. | lld:pubmed |
| pubmed-article:2401674 | pubmed:affiliation | New Era, Kathmandu, Nepal. | lld:pubmed |
| pubmed-article:2401674 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2401674 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
